BSD2.DE vs. NVS
Compare and contrast key facts about Banco Santander S.A (BSD2.DE) and Novartis AG (NVS).
Performance
BSD2.DE vs. NVS - Performance Comparison
Loading graphics...
BSD2.DE vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BSD2.DE Banco Santander S.A | -1.19% | 137.11% | 20.84% | 41.19% | -0.53% | 15.93% | -24.21% | -0.16% | -24.64% | 17.95% |
NVS Novartis AG | 17.69% | 29.51% | 6.62% | 12.65% | 14.76% | 3.55% | -5.17% | 16.49% | 10.92% | 4.74% |
Different Trading Currencies
BSD2.DE is traded in EUR, while NVS is traded in USD. To make them comparable, the NVS values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, BSD2.DE achieves a -1.19% return, which is significantly lower than NVS's 17.69% return. Over the past 10 years, BSD2.DE has outperformed NVS with an annualized return of 14.98%, while NVS has yielded a comparatively lower 11.92% annualized return.
BSD2.DE
- 1D
- 4.53%
- 1M
- -2.50%
- YTD
- -1.19%
- 6M
- 14.61%
- 1Y
- 62.61%
- 3Y*
- 48.27%
- 5Y*
- 32.68%
- 10Y*
- 14.98%
NVS
- 1D
- 1.42%
- 1M
- -3.23%
- YTD
- 17.69%
- 6M
- 23.04%
- 1Y
- 36.03%
- 3Y*
- 20.56%
- 5Y*
- 17.20%
- 10Y*
- 11.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BSD2.DE vs. NVS — Risk / Return Rank
BSD2.DE
NVS
BSD2.DE vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Banco Santander S.A (BSD2.DE) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BSD2.DE | NVS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.99 | 1.73 | +0.26 |
Sortino ratioReturn per unit of downside risk | 2.50 | 2.28 | +0.22 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.30 | +0.03 |
Calmar ratioReturn relative to maximum drawdown | 3.57 | 3.51 | +0.06 |
Martin ratioReturn relative to average drawdown | 12.06 | 9.81 | +2.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BSD2.DE | NVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.99 | 1.73 | +0.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.04 | 0.96 | +0.08 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.61 | -0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 0.53 | -0.42 |
Correlation
The correlation between BSD2.DE and NVS is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BSD2.DE vs. NVS - Dividend Comparison
BSD2.DE's dividend yield for the trailing twelve months is around 2.25%, less than NVS's 3.08% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSD2.DE Banco Santander S.A | 2.25% | 2.23% | 4.44% | 3.71% | 3.92% | 2.60% | 3.87% | 6.15% | 5.62% | 4.03% | 2.05% | 7.56% |
NVS Novartis AG | 3.08% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Drawdowns
BSD2.DE vs. NVS - Drawdown Comparison
The maximum BSD2.DE drawdown since its inception was -78.33%, which is greater than NVS's maximum drawdown of -34.96%. Use the drawdown chart below to compare losses from any high point for BSD2.DE and NVS.
Loading graphics...
Drawdown Indicators
| BSD2.DE | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.33% | -42.10% | -36.23% |
Max Drawdown (1Y)Largest decline over 1 year | -17.87% | -10.76% | -7.11% |
Max Drawdown (5Y)Largest decline over 5 years | -32.08% | -20.42% | -11.66% |
Max Drawdown (10Y)Largest decline over 10 years | -71.03% | -26.03% | -45.00% |
Current DrawdownCurrent decline from peak | -10.52% | -5.23% | -5.29% |
Average DrawdownAverage peak-to-trough decline | -33.80% | -10.94% | -22.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.12% | 3.67% | +1.45% |
Volatility
BSD2.DE vs. NVS - Volatility Comparison
Banco Santander S.A (BSD2.DE) has a higher volatility of 11.18% compared to Novartis AG (NVS) at 5.97%. This indicates that BSD2.DE's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BSD2.DE | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.18% | 5.97% | +5.21% |
Volatility (6M)Calculated over the trailing 6-month period | 21.60% | 13.88% | +7.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.44% | 21.03% | +10.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.15% | 18.06% | +13.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.69% | 19.64% | +14.05% |
Financials
BSD2.DE vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Banco Santander S.A and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities